The association of PLA2G2A single nucleotide polymorphisms with type IIa secretory phospholipase A2 level but not its activity in patients with stable coronary heart disease
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Secretory Phospholipase A2-IIA and Cardiovascular DiseaseJACC, 2013
- Anti-Inflammatory Effects of Varespladib Methyl in Diabetic Patients with Acute Coronary SyndromeCardiovascular Drugs and Therapy, 2011
- Type II Secretory Phospholipase A2 and Prognosis in Patients with Stable Coronary Heart Disease: Mendelian Randomization StudyPLOS ONE, 2011
- Circulating Secretory Phospholipase A2 Activity and Risk of Incident Coronary Events in Healthy Men and WomenArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS studyHuman Molecular Genetics, 2005
- Circulating Secretory Phospholipase A2 Activity Predicts Recurrent Events in Patients With Severe Acute Coronary SyndromesJACC, 2005
- Serum Levels of Type II Secretory Phospholipase A2 and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and WomenArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary interventionEuropean Heart Journal, 2003
- Expression of Phospholipase A 2 Isoforms in Human Normal and Atherosclerotic Arterial WallArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Localization of Nonpancreatic Secretory Phospholipase A 2 in Normal and Atherosclerotic ArteriesArteriosclerosis, Thrombosis, and Vascular Biology, 1997